Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

325 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 325 results

Not applicableNot Yet RecruitingNCT07567378
What this trial is testing

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Who this might be right for
Psoriatic ArthritisOsteoarthitisKnee+12 more
JULIO GRANADOS MONTIEL 30
Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Large-scale testing (Phase 3)Study completedNCT00707031
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 639
Post-approval studies (Phase 4)Study completedNCT01899430
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 32
Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Post-approval studies (Phase 4)Looking for participantsNCT06774079
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Who this might be right for
Crohn Disease
University of Miami 24
Not applicableLooking for participantsNCT06725693
What this trial is testing

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Who this might be right for
GLP1-R-related DiseaseTumorInsulinoma+1 more
Tianjin Medical University 500
Large-scale testing (Phase 3)Study completedNCT00688701
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 361
Large-scale testing (Phase 3)Study completedNCT02042664
What this trial is testing

Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

Who this might be right for
ObesityDiabetes
Assistance Publique Hopitaux De Marseille 44
Not applicableStudy completedNCT06500130
What this trial is testing

Effects of Liraglutide on Body Surface Gastric Mapping

Who this might be right for
GastroparesisFunctional DyspepsiaChronic Nausea and Vomiting Syndrome+1 more
Alimetry 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07428746
What this trial is testing

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Emory University 20
Not applicableLooking for participantsNCT07229170
What this trial is testing

Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

Who this might be right for
Obesity & OverweightTaste AlterationsWeight Loss+1 more
San Raffaele Telematic University 150
Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Early research (Phase 1)Study completedNCT06634927
What this trial is testing

Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68
Not applicableLooking for participantsNCT07006142
What this trial is testing

Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

Who this might be right for
Upper EndoscopyGLP1-R-related Disease
Mayo Clinic 150
Post-approval studies (Phase 4)Enrolling By InvitationNCT07117240
What this trial is testing

Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes

Who this might be right for
Steroid-Induced DiabetesSteroid-Induced HyperglycemiaDiabetes
Medical University of Warsaw 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07218354
What this trial is testing

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
VA Office of Research and Development 622
Testing effectiveness (Phase 2)Looking for participantsNCT07446998
What this trial is testing

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Who this might be right for
Obesity & OverweightMobility DisabilityHOMA-IR
Veru Inc. 200
Not applicableStudy completedNCT01281228
What this trial is testing

The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Obesity
Amsterdam UMC, location VUmc 48
Large-scale testing (Phase 3)Looking for participantsNCT07284511
What this trial is testing

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Who this might be right for
Type 1 DiabetesType 1 Diabetes MellitusT1D+2 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 105
Load More Results